Back
Unicycive Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
UNCY
Unicycive Therapeutics, Inc.
Last Price:
$5.86
Seasonality Move:
72.91%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UNCY is experiencing slight buying pressure.
Unicycive Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.7 | Buy |
| 20-day SMA: | 6.07 | Sell |
| 50-day SMA: | 5.45 | Buy |
| 200-day SMA: | 5.33 | Buy |
| 8-day EMA: | 5.81 | Buy |
| 20-day EMA: | 5.84 | Buy |
| 50-day EMA: | 5.52 | Buy |
| 200-day EMA: | 5.37 | Buy |
Unicycive Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 51.56 | Buy |
| Chaikin Money Flow: | 55439 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.55 - 6.37) | Sell |
| Bollinger Bands (100): | (4.08 - 5.62) | Buy |
Unicycive Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Unicycive Therapeutics, Inc. Stock
Is Unicycive Therapeutics, Inc. Stock a Buy?
-
Unicycive Therapeutics, Inc. share price is 5.86 while UNCY 8-day simple moving average is 5.70, which is a Buy signal.
-
The stock price of UNCY is 5.86 while Unicycive Therapeutics, Inc. 20-day SMA is 6.07, which makes it a Sell.
-
Unicycive Therapeutics, Inc. 50-day simple moving average is 5.45 while UNCY share price is 5.86, making it a Buy technically.
-
UNCY stock price is 5.86 and Unicycive Therapeutics, Inc. 200-day simple moving average is 5.33, creating a Buy signal.
UNCY Technical Analysis vs Fundamental Analysis
Sell
45
Unicycive Therapeutics, Inc. (UNCY)
is a Sell
Is Unicycive Therapeutics, Inc. a Buy or a Sell?
-
Unicycive Therapeutics, Inc. stock is rated a SellThe current Unicycive Therapeutics, Inc. [UNCY] share price is $5.86. The Score for UNCY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Unicycive Therapeutics, Inc. Stock Info
Market Cap:
125.9M
Price in USD:
5.86
Share Volume:
115.9K
Unicycive Therapeutics, Inc. 52-Week Range
52-Week High:
11.00
52-Week Low:
3.71
Sell
45
Unicycive Therapeutics, Inc. (UNCY)
is a Sell
Unicycive Therapeutics, Inc. Share Price Forecast
-
What is the Unicycive Therapeutics, Inc. stock price today?The Unicycive Therapeutics, Inc. stock price is 5.86 USD today.
-
Will UNCY stock go up or go down?Unicycive Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Unicycive Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Unicycive Therapeutics, Inc. is overvalued.
Is Unicycive Therapeutics, Inc. Stock a Buy?
-
Unicycive Therapeutics, Inc. share price is 5.86 while UNCY 8-day exponential moving average is 5.81, which is a Buy signal.
-
The stock price of UNCY is 5.86 while Unicycive Therapeutics, Inc. 20-day EMA is 5.84, which makes it a Buy.
-
Unicycive Therapeutics, Inc. 50-day exponential moving average is 5.52 while UNCY share price is 5.86, making it a Buy technically.
-
UNCY stock price is 5.86 and Unicycive Therapeutics, Inc. 200-day simple moving average is 5.37, creating a Buy signal.
Fundamental Analysis of Unicycive Therapeutics, Inc.
Is Unicycive Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $2.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.02 per share, and an increase next year of $6.99 per share.
Technical Analysis of Unicycive Therapeutics, Inc.
Should I short Unicycive Therapeutics, Inc. stock?
-
UNCY Moving Average Covergence Divergence (MACD) indicator is 0.06, suggesting Unicycive Therapeutics, Inc. is a Buy
-
Unicycive Therapeutics, Inc. Relative Strength Index (RSI) is 51.56, which suggest Unicycive Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Unicycive Therapeutics, Inc. is (5.55 - 6.37), which suggest Unicycive Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Unicycive Therapeutics, Inc. is (4.08 - 5.62), which suggest Unicycive Therapeutics, Inc. is a Buy
* Unicycive Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.